- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 90 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Report
- January 2022
- 90 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Report
- February 2021
- 35 Pages
Global
From €2260EUR$2,275USD£1,879GBP
€3229EUR$3,250USD£2,684GBP
- Report
- December 2020
- 60 Pages
Global
From €2260EUR$2,275USD£1,879GBP
€3229EUR$3,250USD£2,684GBP
- Report
- July 2019
Global
From €695EUR$700USD£578GBP
€993EUR$1,000USD£826GBP
- Report
- July 2019
Global
From €695EUR$700USD£578GBP
€993EUR$1,000USD£826GBP
- Report
- September 2023
- 146 Pages
Global
From €3298EUR$3,320USD£2,742GBP
€4123EUR$4,150USD£3,428GBP
- Report
- September 2024
- 82 Pages
Japan
From €3477EUR$3,500USD£2,891GBP
- Report
- August 2024
- 82 Pages
Japan
From €3477EUR$3,500USD£2,891GBP
- Report
- August 2024
- 82 Pages
Japan
From €3477EUR$3,500USD£2,891GBP
- Report
- November 2023
- 180 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 181 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 185 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 90 Pages
United States
From €3477EUR$3,500USD£2,891GBP
- Report
- October 2023
- 71 Pages
India
From €3477EUR$3,500USD£2,891GBP
- Report
- October 2023
- 173 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 181 Pages
Global
From €4471EUR$4,500USD£3,717GBP
The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more